Access cutting-edge antiphospholipid syndrome treatment through this clinical trial at a research site in Salt Lake City. Study-provided care at no cost to qualified participants.
Access antiphospholipid syndrome specialists in Salt Lake City at no cost
This study follows strict safety protocols and ethical guidelines
All study-related antiphospholipid syndrome treatment provided free
This treatment trial evaluates the addition of an anti-tumor necrosis factor-alpha drug, certolizumab, to usual treatment (a heparin agent and low-dose aspirin) in pregnant women with antiphospholipid syndrome (APS) and repeatedly positive tests for lupus anticoagulant (LAC) to determine if this regimen will improve pregnancy outcomes. All enrolled patients will receive certolizumab, and pregnancy outcomes will be compared to those of women with APS and repeatedly positive tests for LAC enrolled
Sponsor: David Ware Branch
Check if you qualify for this antiphospholipid syndrome clinical trial in Salt Lake City, UT
If you're searching for antiphospholipid syndrome treatment options in Salt Lake City, UT, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Salt Lake City research site is actively enrolling participants for this clinical trial. You'll receive care from experienced antiphospholipid syndrome specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.